New‐onset sarcoidosis in a patient with long COVID

Guillermo Rodriguez‐Nava; Vanessa El Kamari; Harvey Chang; Goar Egoryan; Hector F. Bonilla

doi:10.1002/ccr3.9186

Clinical Case Reports (Aug 2024)

New‐onset sarcoidosis in a patient with long COVID

Guillermo Rodriguez‐Nava,
Vanessa El Kamari,
Harvey Chang,
Goar Egoryan,
Hector F. Bonilla

Affiliations

Guillermo Rodriguez‐Nava: Division of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA
Vanessa El Kamari: Division of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA
Harvey Chang: Department of Pathology Memorial Medical Center Modesto California USA
Goar Egoryan: Division of Oncology, Department of Medicine Stanford University School of Medicine Stanford California USA
Hector F. Bonilla: Division of Infectious Diseases and Geographic Medicine, Department of Medicine Stanford University School of Medicine Stanford California USA

DOI: https://doi.org/10.1002/ccr3.9186
Journal volume & issue: Vol. 12, no. 8
pp. n/a – n/a

Abstract

Read online

Key Clinical Message Long COVID, often following SARS‐CoV‐2 infection, may stem from sustained inflammation, overlapping with autoimmune diseases like sarcoidosis. Though specific treatments lack, this link could shape future diagnostic and therapeutic methods.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords